Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections
Hilal Ahmad Parray, Shivangi Shukla, Reshma Perween, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 16-17, pp. 6315-6332
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Designing antibodies as therapeutics
Paul J. Carter, Arvind Rajpal
Cell (2022) Vol. 185, Iss. 15, pp. 2789-2805
Open Access | Times Cited: 137
Biologics, theranostics, and personalized medicine in drug delivery systems
Matteo Puccetti, Marilena Pariano, Aurélie Schoubben, et al.
Pharmacological Research (2024) Vol. 201, pp. 107086-107086
Open Access | Times Cited: 64
Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
Eknath Kole, Krishna Jadhav, Nitin Shirsath, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 81, pp. 104261-104261
Closed Access | Times Cited: 42
Modified chitosan: Insight on biomedical and industrial applications
Great Iruoghene Edo, Emad͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏ Yousif, Mohammed H. Al‐Mashhadani
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133526-133526
Closed Access | Times Cited: 27
Therapeutic Antibodies in Medicine
Prerna Sharma, Rahul V. Joshi, Robert C. Pritchard, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6438-6438
Open Access | Times Cited: 29
Engineered Polymer–siRNA Polyplexes Provide Effective Treatment of Lung Inflammation
Taewon Jeon, David C. Luther, Ritabrita Goswami, et al.
ACS Nano (2023) Vol. 17, Iss. 5, pp. 4315-4326
Open Access | Times Cited: 25
Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine
Elena Cojocaru, Ovidiu Rusalim Petriș, Cristian Cojocaru
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1059-1059
Open Access | Times Cited: 8
Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
Grzegorz Kardas, Michał Panek, Piotr Kuna, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Engineering ACE2 decoy receptors to combat viral escapability
Takao Arimori, Nariko Ikemura, Toru Okamoto, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 10, pp. 838-851
Open Access | Times Cited: 32
Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals
Fakhrossadat Emami, Mahsa Keihan Shokooh, Seyed Jamaleddin Mostafavi Yazdi
Journal of Pharmaceutical Investigation (2022) Vol. 53, Iss. 1, pp. 35-57
Open Access | Times Cited: 32
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
Emiko Urano, Yumi Itoh, Tatsuya Suzuki, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 711
Closed Access | Times Cited: 19
A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases
Fabian Bohländer
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
Michael S. Piepenbrink, Jun‐Gyu Park, Ashlesha Deshpande, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 7, pp. e1010691-e1010691
Open Access | Times Cited: 27
Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19
Shohreh Alipour, Laleh Mahmoudi, Fatemeh Ahmadi
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 3, pp. 705-715
Open Access | Times Cited: 25
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration
Huan Ma, Xinghai Zhang, Weihong Zeng, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes
Hsuan‐Ping Chang, Huyen Khanh Le, Dhaval K. Shah
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1132-1132
Open Access | Times Cited: 15
Emerging trends and therapeutic applications of monoclonal antibodies
M. Janaki Ramaiah, Hari P. Nalluri, Prakash Narayana Reddy, et al.
Gene (2024) Vol. 925, pp. 148607-148607
Closed Access | Times Cited: 5
Influenza A Virus H7 nanobody recognizes a conserved immunodominant epitope on hemagglutinin head and confers heterosubtypic protection
Zhao-Shan Chen, Hsiang‐Chi Huang, Xiangkun Wang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Targeting Non-Eosinophilic Immunological Pathways in COPD and AECOPD: Current Insights and Therapeutic Strategies
Dur E Maknoon Razia, Chencheng Gao, Chao Wang, et al.
International Journal of COPD (2025) Vol. Volume 20, pp. 511-532
Open Access
Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
Eugenia Quirós-Roldán, Silvia Amadasi, Isabella Zanella, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1272-1272
Open Access | Times Cited: 31
Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
Han Cong Seow, Jian‐Piao Cai, Harry W. Pan, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 128-141
Open Access | Times Cited: 12
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
Daniel N. Streblow, Alec J. Hirsch, Jeffrey J. Stanton, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin
Siqi Xu, Y. H. Liu, C. L. Luo, et al.
Journal of Virology (2025)
Open Access
Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeutics
Vaishali Verma, N. D. Sinha, A. Raja
mAbs (2025) Vol. 17, Iss. 1
Open Access
Advancements in biologic therapy in eosinophilic asthma
Rini Patadia, Thomas B. Casale, John R. Fowler, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 4, pp. 251-261
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top